OTC Watch

All stocks / NIKA

NIKA PHARMACEUTICALS, INC NIKA

NIKA Pharmaceuticals (NIKA): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated float OTCQBNevada, USA
Live quote on OTC Markets

Market listing

Full name
NIKA PHARMACEUTICALS INC
Market tier
OTCQB
Trading status
Active
Last trade
Oct 28
Website
www.nikapharmaceuticals.com/
Source: Stockwatch, 2026-11-17

News headlines

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
2026-08-25 10:13 · News Release
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
2026-06-04 10:10 · News Release
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
2026-03-06 11:59 · News Release
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
2025-12-03 11:59 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Net loss
($76,398)
What it means

It spends more than it earns

Under strain

The company lost $76,398 in the year. It reported no sales.

The report says
Cash and cash equivalents
$1,889
Net cash used in operating activities
($79,654)
What it means

The cash could run out soon

Under strain

It had $1,889 in the bank and used about $6,638 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$20,996
Total liabilities
$318,624
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $20,996. Its debts and unpaid bills add up to $318,624. That is about $15.18 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-10-15

Estimated float about 1,054,689,224 shares as of 2026-10-15: 1,054,689,224 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-12-31
1.05B
2026-03-09
1.05B
2026-03-31
1.05B
2026-04-01
1.05B
2026-06-30
1.05B
2026-07-04
1.05B
2026-09-30
1.05B
2026-10-15
1.05B

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-10 10-QFORM 10-Q
2026-08-10 10-Q
2026-05-12 10-QFORM 10-Q
2026-03-25 10-K

Common questions about NIKA

Does NIKA file reports with the SEC?

Yes. NIKA Pharmaceuticals files with the SEC under company number 0001145604. The most recent filing we hold is a 10-Q dated 2026-11-10.

Source record

How many NIKA shares are outstanding?

1,054,689,224 shares as of 2026-10-15, as reported to the SEC.

Source record

Has NIKA filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is NIKA Pharmaceuticals making money?

The company lost $76,398 in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record